Pharma Growth Strategy
Strategic Partner for Business Growth
Providing Everything You Need
Scientific Solutions
-
Align scientific strategies to portfolio gaps and market needs
-
Repurposing Portfolio Drugs
-
Identify and evaluate external assets for In-licensing deals
-
First-in-India Strategy: Unlock global assets not yet launched locally
-
Scout novel and emerging targets with high translational value
Portfolio Evaluation
-
Assess company’s portfolio to identify scientific and strategic gaps across indications, modalities, or development stages
-
Understand company’s goals and strengths to deliver focused solutions
-
Assess unmet needs across disease areas to prioritize high-potential therapeutic opportunities.
Cost and Revenue Models
-
Comprehensive cost planning across development and regulatory phases
-
Revenue projections for internal and out-licensed assets, based on market potential and strategic deal assessment
-
Scenario modeling and risk-adjusted forecasting to support investment decisions and partnership deals​